About:
Jillion Therapeutics Inc., a cutting-edge Biotechnology start-up, harnesses neuroscience Nobel Prize-winning lab knowledge, 20+ years’ experience. Jillion excels in organic chemistry while also possessing a broad expertise in biology, ranging from molecular biology to cellular processes. With a robust focus on innovative drug-target identification, Jillion excels in drug screening through DNA-encoded library (DEL) technology and DEL-focused library construction, as well as in thorough target validation.